Ligand validation:4Q50

OHT: 4-HYDROXYTAMOXIFEN

OHT is a Ligand Of Interest in 4Q50 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4Q50_OHT_F_1000	57%	50%	0.187	0.965	0.6	1.31	-	7	0	0	100%	1
4Q50_OHT_D_1000	57%	37%	0.199	0.975	0.79	1.74	1	10	2	0	100%	1
4Q50_OHT_G_1000	54%	44%	0.195	0.963	0.55	1.65	-	8	0	0	100%	1
4Q50_OHT_E_1000	54%	55%	0.203	0.97	0.7	1	-	2	0	0	100%	1
4Q50_OHT_B_601	53%	50%	0.204	0.967	0.68	1.24	-	4	0	0	100%	1
4Q50_OHT_C_1000	45%	44%	0.229	0.964	0.78	1.43	-	6	3	0	100%	1
4Q50_OHT_H_601	41%	36%	0.231	0.946	0.65	1.91	-	11	2	0	100%	1
4Q50_OHT_A_1000	39%	49%	0.266	0.976	0.52	1.45	-	8	0	0	100%	1
2JF9_OHT_A_600	95%	34%	0.064	0.968	1.57	1.16	4	4	0	0	100%	1
2BJ4_OHT_B_1530	78%	26%	0.095	0.937	1.65	1.49	4	6	0	0	100%	1
5W9C_OHT_D_601	76%	5%	0.106	0.942	2.13	3.34	10	12	3	0	100%	1
2GPU_OHT_A_459	70%	51%	0.098	0.915	0.71	1.18	-	3	0	0	100%	1
7UJ8_OHT_B_601	64%	71%	0.138	0.939	0.42	0.68	-	1	1	0	100%	1
2GPV_OHT_C_502	63%	49%	0.149	0.947	0.8	1.16	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.